Daron Evans - Net Worth and Insider Trading

Daron Evans Net Worth

The estimated net worth of Daron Evans is at least $762,185 dollars as of 2024-04-26. Daron Evans is the CFO of Rezolute Inc and owns about 159,900 shares of Rezolute Inc (RZLT) stock worth over $415,740. Daron Evans is also the President and CEO of Nephros Inc and owns about 158,194 shares of Nephros Inc (NEPH) stock worth over $346,445. Details can be seen in Daron Evans's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Daron Evans has not made any transactions after 2024-03-15 and currently still holds the listed stock(s).

Transaction Summary of Daron Evans

To

Daron Evans Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Daron Evans owns 2 companies in total, including Nephros Inc (NEPH) , and Capricor Therapeutics Inc (CAPR) .

Click here to see the complete history of Daron Evans’s form 4 insider trades.

Insider Ownership Summary of Daron Evans

Ticker Comapny Transaction Date Type of Owner
NEPH Nephros Inc 2020-03-12 director & President and CEO
CAPR Capricor Therapeutics Inc 2009-06-24 Chief Financial Officer

Daron Evans Latest Holdings Summary

Daron Evans currently owns a total of 2 stocks. Among these stocks, Daron Evans owns 159,900 shares of Rezolute Inc (RZLT) as of March 15, 2024, with a value of $415,740 and a weighting of 54.55%. Daron Evans also owns 158,194 shares of Nephros Inc (NEPH) as of March 12, 2020, with a value of $346,445 and a weighting of 45.45%.

Latest Holdings of Daron Evans

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RZLT Rezolute Inc 2024-03-15 159,900 2.60 415,740
NEPH Nephros Inc 2020-03-12 158,194 2.19 346,445

Holding Weightings of Daron Evans


Daron Evans Form 4 Trading Tracker

According to the SEC Form 4 filings, Daron Evans has made a total of 3 transactions in Rezolute Inc (RZLT) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Rezolute Inc is the acquisition of 20,000 shares on March 15, 2024, which cost Daron Evans around $33,800.

According to the SEC Form 4 filings, Daron Evans has made a total of 5 transactions in Nephros Inc (NEPH) over the past 5 years, including 5 buys and 0 sells. The most-recent trade in Nephros Inc is the acquisition of 2,500 shares on March 12, 2020, which cost Daron Evans around $16,625.

Insider Trading History of Daron Evans

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Daron Evans Trading Performance

GuruFocus tracks the stock performance after each of Daron Evans's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Daron Evans is 40.63%. GuruFocus also compares Daron Evans's trading performance to market benchmark return within the same time period. The performance of stocks bought by Daron Evans within 3 months outperforms 8 times out of 9 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Daron Evans's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Daron Evans

Average Return

55.67%

Average return per transaction

Outperforming Transactions

78%

7 out of 9 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 24.16 40.63 39.66 55.67 26.93 -4.55
Relative Return to S&P 500(%) 22.8 32.83 28.59 35.68 10.46 -16.27

Daron Evans Ownership Network

Ownership Network List of Daron Evans

No Data

Ownership Network Relation of Daron Evans


Daron Evans Owned Company Details

What does Nephros Inc do?

Who are the key executives at Nephros Inc?

Daron Evans is the director & President and CEO of Nephros Inc. Other key executives at Nephros Inc include director & President and CEO Banks Robert R. Jr. , Chief Financial Officer Judy Krandel , and Chief Marketing Officer Wesley S. Lobo .

Nephros Inc (NEPH) Insider Trades Summary

Over the past 18 months, Daron Evans made no insider transaction in Nephros Inc (NEPH). Other recent insider transactions involving Nephros Inc (NEPH) include a net purchase of 20,000 shares made by Banks Robert R. Jr. , and a net purchase of 7,000 shares made by Arthur H Amron .

In summary, during the past 3 months, insiders sold 0 shares of Nephros Inc (NEPH) in total and bought 7,000 shares, with a net purchase of 7,000 shares. During the past 18 months, 0 shares of Nephros Inc (NEPH) were sold and 27,000 shares were bought by its insiders, resulting in a net purchase of 27,000 shares.

Nephros Inc (NEPH)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Nephros Inc Insider Transactions

No Available Data

Daron Evans Mailing Address

Above is the net worth, insider trading, and ownership report for Daron Evans. You might contact Daron Evans via mailing address: C/o Nephros, Inc., 380 Lackawanna Place, South Orange Nj 07079.

Discussions on Daron Evans

No discussions yet.